Virbac SA (VIRP.PA)
Makes medicines and food for pets and farm animals worldwide.
345.50+0.03%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+1.6%
The outlook
Virbac trades at €345.50 with analyst consensus solidly on the buy side, and the average price target sits about 19% above the current level. The stock sits roughly midway in its 52-week range with mixed momentum versus its moving averages, suggesting neither strong uptrend nor downtrend at present. The trailing P/E of 19.2 reflects moderate valuation relative to earnings.
What’s behind the score
Analyst consensusBuy — 1.6 avg of 8 analysts
Price trendMixed vs its moving averages
52-week range53% of the way from its 52-week low to high
Price targetAvg target +19% vs current price
Analyst price target
~12-month · 8 analysts412.00average target+19.2% vs now
Now 345.50
Low 361.00High 440.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$2.90B
52-wk high
389.50
52-wk low
296.00
50-day avg
340.10
200-day avg
351.79
Trailing P/E
19.2